Overdiagnosis in Colorectal Cancer Screening – Time to Acknowledge A Blind Spot
Overdiagnosis is recognized as a major harm of mammography screening for breast cancer and prostate cancer screening with prostate-specific-antigen (PSA). Colorectal cancer screening is being more broadly implemented in many countries, and screening rates are increasing steadily. Surprisingly, there is a striking and almost complete lack of knowledge about overdiagnosis in colorectal cancer screening. Overdiagnosis is not part of patient information material, hardly mentioned in guidelines, and not addressed in scientific or public debate.
Source: Gastroenterology - Category: Gastroenterology Authors: Mette Kalager, Paulina Wieszczy, Iris Lansdorp-Vogelaar, Douglas A. Corley, Michael Bretthauer, Michal F. Kaminski Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Colorectal Cancer | Eyes | Gastroenterology | Mammography | Men | Prostate Cancer